High Resolution Imaging for Prostate Cancer

High Resolution Diffusion Weighted Imaging in Prostate

Recruiting Observational Study
Prostate Cancer Prostate Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 and older
Sex
Male
Study type
Observational
Participants needed
500 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Other
Who this trial is looking for

This trial is looking for men who have had standard MRI scans done for prostate issues. Participants will help test a new imaging technique that may give clearer pictures of the prostate.

Are You a Good Fit for This Trial?
Must not be taking 5-alpha-reductase inhibitors

You may be able to join if

  • I have had standard MR scanning including T2WI, cDWI, and hrDWI.
  • I have complete clinical information.

You may not be able to join if

  • I have used 5-alpha-reductase inhibitors in the last six months.
  • I have had a prostatic biopsy.
  • I have had prostatic surgery.
  • I have received treatment for prostate cancer.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

hrDWI might be an alternative to cDWI for the prostate imaging. 1. increase the signal-to-noise ratio and contrast-to-noise ratio, yielding high-fidelity images with less noise in general 2. improve the diagnostic accuracy of PCa in particular than conventional DWI

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients who underwent standard MR scanning including T2WI, cDWI , hrDWI and respective calculated apparent diffusion coefficient (ADC) maps; 2. Complete clinical information. Exclusion Criteria: Men were excluded if they were using 5-alpha-reductase inhibitors at time of e…
Contacts

Yu-Dong Zhang

86-18251966069

njmu_zyd@163.com

CONTACT